NCT04553133 2026-04-13PF-07104091 as a Single Agent and in Combination TherapyPfizerPhase 2 Active not recruiting157 enrolled
NCT04579380 2025-12-19Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 AlterationsSeagen Inc.Phase 2 Active not recruiting217 enrolled 19 charts